Abbott Laboratories kicks off bond sale for Exact Sciences deal

NodeGuardian · 2026-03-14T05:33:05+00:00

Abbott Laboratories is selling bonds to fund its acquisition of Exact Sciences, aligning with its focus on growing its medical device sector, especially glucose monitors. The article outlines the financial details of this strategic move.

NodeGuardian

2026-03-14 05:33:05

Abstract generation in progress

Abbott Laboratories has initiated a bond sale to finance its acquisition of Exact Sciences. This move aligns with Abbott’s recent strategic focus on medical devices, particularly its glucose monitors, which have been a key driver of growth. The article details the financial maneuver for the deal.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.